These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28573869)

  • 1. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection.
    Hou AW; Morrill AM
    Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obiltoxaximab (Anthim) for inhalation anthrax.
    Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
    [No Abstract]   [Full Text] [Related]  

  • 4. Obiltoxaximab: First Global Approval.
    Greig SL
    Drugs; 2016 May; 76(7):823-30. PubMed ID: 27085536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans.
    Nagy CF; Leach TS; King A; Guttendorf R
    Clin Pharmacol Drug Dev; 2018 Aug; 7(6):652-660. PubMed ID: 29125719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule.
    Nagy CF; Mondick J; Serbina N; Casey LS; Carpenter SE; French J; Guttendorf R
    Clin Transl Sci; 2017 Jan; 10(1):12-19. PubMed ID: 27925405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; O'Connor E; Gonzales N; Mondick J; French J; Stark GV; Fisher AC; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5787-95. PubMed ID: 27431222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies.
    Nagy CF; Leach TS; Hoffman JH; Czech A; Carpenter SE; Guttendorf R
    Clin Ther; 2016 Sep; 38(9):2083-2097.e7. PubMed ID: 27568215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins.
    Slay RM; Cook R; Hendricks K; Boucher D; Merchlinsky M
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S441-S450. PubMed ID: 36251555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?
    Antoniu SA
    Expert Opin Investig Drugs; 2010 Jul; 19(7):909-11. PubMed ID: 20450444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raxibacumab for the treatment of inhalational anthrax.
    Migone TS; Subramanian GM; Zhong J; Healey LM; Corey A; Devalaraja M; Lo L; Ullrich S; Zimmerman J; Chen A; Lewis M; Meister G; Gillum K; Sanford D; Mott J; Bolmer SD
    N Engl J Med; 2009 Jul; 361(2):135-44. PubMed ID: 19587338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans.
    Malkevich NV; Hopkins RJ; Bernton E; Meister GT; Vela EM; Atiee G; Johnson V; Nabors GS; Aimes RT; Ionin B; Skiadopoulos MH
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3618-25. PubMed ID: 24733473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Efficacy of FDA-Approved
    Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax.
    Tournier JN; Rougeaux C; Biot FV; Goossens PL
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31217301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study evaluating the safety and pharmacokinetics of MDX-1303, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers.
    Riddle V; Leese P; Blanset D; Adamcio M; Meldorf M; Lowy I
    Clin Vaccine Immunol; 2011 Dec; 18(12):2136-42. PubMed ID: 21976227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pre-approved and novel therapies for the treatment of anthrax.
    Head BM; Rubinstein E; Meyers AF
    BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.